Scarica l'app Stockscreener
4.325
17.85%
0.655
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.67
Aprire:
$3.8
Volume 24 ore:
4.73M
Relative Volume:
2.17
Capitalizzazione di mercato:
$386.43M
Reddito:
-
Utile/perdita netta:
$-48.17M
Rapporto P/E:
-7.5877
EPS:
-0.57
Flusso di cassa netto:
$-37.10M
1 W Prestazione:
+12.05%
1M Prestazione:
-44.12%
6M Prestazione:
-44.83%
1 anno Prestazione:
-51.84%
Intervallo 1D:
$3.80
$4.84
Intervallo di 1 settimana:
$3.62
$4.84
Portata 52W:
$2.86
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corporation
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Confronta AVXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
4.325 | 327.91M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.75 | 109.90B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
732.11 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
476.02 | 61.42B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
928.95 | 56.36B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.60 | 44.06B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie
Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL) - Finviz
Can Anavex Life Sciences Corp. (12X1) stock sustain institutional flowsMarket Risk Summary & Technical Buy Zone Confirmations - Newser
Check Out Anavex Life Sciences Corporation (AVXL)’s Trade Data Rather Than the Analysts’ Views - Setenews
What analysts say about Anavex Life Sciences Corp stockEarnings Miss Alerts & Superior Capital Trading - earlytimes.in
Why Anavex Life Sciences Corp. stock could rally in 2025July 2025 Sector Moves & Low Risk High Reward Ideas - BỘ NỘI VỤ
D. Boral Capital Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences’ (AVXL) Buy Rating Reiterated at D. Boral Capital - Defense World
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at D. Boral Capital - Defense World
Anavex Life Sciences And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Anavex (NASDAQ: AVXL) to present blarcamesine Phase IIb/III Alzheimer’s results at CTAD - Stock Titan
Anavex Life Sciences Corp (AVXL) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Anavex Life Sciences Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2025 - MarketScreener
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update - MarketScreener
Anavex Life Sciences (NASDAQ: AVXL) Quarter 2025 Reports $102.6M, Three-Year Runway - Stock Titan
You might want to take a look at Anavex Life Sciences Corporation (AVXL) now - Setenews
Will Anavex Life Sciences Corp. stock rally after Fed decisions2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com
Can Anavex Life Sciences Corp. stock maintain operating marginsWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
How Anavex Life Sciences Corp. (12X1) stock trades after rate cuts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - cnhinews.com
Anavex Life Sciences Corp. to Release Fiscal Year End Financial Results on November 25, 2025 - Quiver Quantitative
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 - MarketScreener
Anavex Life Sciences (Nasdaq: AVXL) to Report Fiscal 2025 Results on Nov. 25 - Stock Titan
A significant driver of top-line growth: Anavex Life Sciences Corporation (AVXL) - Setenews
Why Anavex Life Sciences (AVXL) Is Down 43.8% After EMA Setback for Lead Alzheimer’s Drug - Yahoo Finance
Can Anavex Life Sciences Corp. stock deliver strong Q4 earnings2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Is Anavex Life Sciences Corp. stock resilient to inflationWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
Will Anavex Life Sciences Corp. (12X1) stock rise with strong economyJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
Anavex Life Sciences Shares Plummet Following EU Regulatory Setback - StocksToTrade
Anavex Life Sciences Stock Plummets Amid Regulatory Hurdles - StocksToTrade
How strong is Anavex Life Sciences Corp. stock revenue growthQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Will Anavex Life Sciences Corp. (12X1) stock deliver compounding returns2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
Can Anavex Life Sciences Corp. stock attract ESG capital inflowsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
Anavex Life Sciences Corp. (AVXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month LowHere's Why - MarketBeat
Real time breakdown of Anavex Life Sciences Corp. stock performance2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Micron Tech, Netflix among market cap stock movers on Friday By Investing.com - Investing.com UK
Micron Tech, Netflix among market cap stock movers on Friday - Investing.com
Anavex Life Sciences Crashes as EMA Setback Sparks Doubts on Lead Alzheimer Drug - Investing.com
Anavex Life Sciences Corp. Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease - MarketScreener
Anavex Life Sciences Falls in Premarket Trading After Alzheimer's Drug Receives EU Regulatory Setback - MarketScreener
Anavex Faces CHMP Setback for Alzheimer’s Drug - MSN
Anavex Life Sciences Plans Re-examination Request Following CHMP Feedback and FDA Meeting on Alzheimer's Disease Trial Results - Quiver Quantitative
Anavex (NASDAQ: AVXL) to seek CHMP re-exam; formal opinion expected in December - Stock Titan
Morning Market Movers: CDTX, BCG, IVVD, TSSI See Big Swings - RTTNews
Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug - ts2.tech
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? - Stocktwits
Anavex drops 11% as Martin Shkreli says the pharma is his next short - Seeking Alpha
Ready to Jump After Recent Trade: Anavex Life Sciences Corporation (AVXL) - Setenews
Why Anavex Life Sciences Corp. (12X1) stock could be next leaderMarket Sentiment Review & Comprehensive Market Scan Reports - newser.com
Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anavex Life Sciences Corporation Azioni (AVXL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thomas Steffen | Director |
Jun 05 '25 |
Option Exercise |
1.76 |
50,000 |
88,000 |
55,000 |
| MISSLING CHRISTOPHER U | President and CEO |
Mar 24 '25 |
Option Exercise |
0.92 |
500,000 |
460,000 |
1,750,210 |
0.73%
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):